The Impact of Diagnostic Criteria for Gestational Diabetes Mellitus on Adverse Maternal Outcomes: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
This systematic review and meta-analysis aimed to examine the impact of different gestational-diabetes (GDM) diagnostic-criteria on the risk of adverse-maternal-outcomes. The search process encompassed PubMed (Medline), Scopus, and Web of Science databases to retrieve original, population-based studies with the universal GDM screening approach, published in English language and with a focus on adverse-maternal-outcomes up to January 2020. According to GDM diagnostic criteria, the studies were classified into seven groups. A total of 49 population-based studies consisting of 1409018 pregnant women with GDM and 7,667,546 non-GDM counterparts were selected for data analysis and knowledge synthesis. Accordingly, the risk of adverse-maternal-outcomes including primary-cesarean, induction of labor, maternal-hemorrhage, and pregnancy-related-hypertension, overall, regardless of GDM diagnostic-criteria and in all diagnostic-criteria subgroups were significantly higher than non-GDM counterparts. However, in meta-regression, the increased risk was not influenced by the GDM diagnostic-classification and the magnitude of the risks among patients, using the IADPSG criteria-classification as the most strict-criteria, was similar to other criteria. In conclusion, a reduction in the diagnostic-threshold increased the prevalence of GDM, but the risk of adverse-maternal-outcome was not different among those women who were diagnosed through more or less intensive strategies. Our review findings can empower health-care-providers to select the most cost-effective approach for the screening of GDM among pregnant women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A global consensus has not been reached about the diagnostic criteria for HDP and GDM, making it challenging to assess differences in their disease burden between countries and areas.”
From A global view of hypertensive disorders and diabetes mellitus during pregnancy (2022) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Currently, the screening and diagnostic approaches for GDM are under debate24–32 given differences in the focus of different guidelines.”
From A global view of hypertensive disorders and diabetes mellitus during pregnancy (2022) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329 · cited 1×
“The (ROBINS) tool in non-randomized studies of interventions and observational studies was used for assessing the risk of bias [18], which has been recommended by the Cochrane [19].”
MethodStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“For quality appraisal, the modified Newcastle-Ottawa Quality Assessment Scale was used [17].”
MethodPreferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
The Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874 · cited 1×
“Chronic disturbances in maternal β-cell, release of diabetogenic peptides from the placenta, and hormones may play a key role in the pathophysiology of GDM [5].”
BackgroundHoffman, L., Nolan, C., Wilson, J. D., Oats, J. J. N., & Simmons, D. (1998) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140192.x · Cited by 570
Hyperglycemia and Adverse Pregnancy Outcomes
Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., Hadden, D. R., McCance, D. R., Hod, M., McIntyre, H. D., et al. (2009) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000344706.95925.dc · Cited by 479
Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes
Xiong, X., Saunders, L. D., Wang, F. L., & Demianczuk, N. N. (2001) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(01)00496-9 · Cited by 399 · cited 1×
“…20.6 vs. 22.3 vs. 16.6 Soliman et al., 2018 Qatar IADPSG n = 3027 n = 8995 Hypertensive disorders: 5.5 vs. 3.5; Labor induction: 26.5 vs. 12.4 Xiong et al., 2001 Canada CDA n = 2755 n = 8995 Gestational hypertension: 11.4 vs. 4.8; Pre-eclampsia: 1.1 vs. 1.1 Oster et al., 2014 Canada CDA n =…”
InfluentialWeissgerber, T. L., & Mudd, L. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0579-4 · Cited by 357
Research works printed but not linked: 2
- Higgins, J., and Green, S. (2011). Analysing data and undertaking meta-analyses In Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1. 0), Wiley.
- ACOG (2018). Gestational Diabetes Mellitus, ACOG. ACOG Practice Bulletin.
Cited by
A global view of hypertensive disorders and diabetes mellitus during pregnancy
Jiang, L., Tang, K., Magee, L. A., von Dadelszen, P., Ekeroma, A., Li, X., Zhang, E., & Bhutta, Z. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00734-y · Cited by 314
Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0
Ruszała, M., Pilszyk, A., Niebrzydowska-Tatus, M., Kimber-Trojnar, Ż., Trojnar, M. P., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084364 · Cited by 44
“Given the various diagnostic criteria and ethnicity, in many countries the epidemiology of GDM still remains unknown [8,9].”
BackgroundUpdate on gestational diabetes and adverse pregnancy outcomes
Ugwudike, B., & Kwok, M. H. (2023) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000901 · Cited by 38
Tehrani, F. R., Naz, M. S. G., Yarandi, R. B., & Behboudi‐Gandevani, S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0178 · Cited by 37
“org GDM screening strategies classifications [99].”
Self-citationMahmoud, E., Elsayed, A. M., Elsayed, B. M. S., Elsalakawi, Y., Gopinath, A., & Chivese, T. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-091258 · Cited by 34
The Role of Kisspeptin in the Pathogenesis of Pregnancy Complications: A Narrative Review
Szydełko-Gorzkowicz, M., Poniedziałek‐Czajkowska, E., Mierzyński, R., Sotowski, M., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126611 · Cited by 30
Nawsherwan, N., Liu, Z., Zhang, L., Mubarik, S., Sun, Y., Naeem, S., & Li, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1267338 · Cited by 27
Lin, D., Fan, D., Li, P., Chen, G., Rao, J., Zhou, Z., Zhang, H., Luo, X., Ma, H., Feng, J., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.946186 · Cited by 21
Management of Placental Transfusion to Neonates After Delivery
McAdams, R. M., & Lakshminrusimha, S. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004625 · Cited by 23
Pintaudi, B., Vieste, G. D., D’Anna, R., Chiereghin, F., Biamonte, E., Corrado, F., & Benedetto, A. D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030564 · Cited by 22
“, primary cesarean, induction of labor, maternal hemorrhage, and pregnancy-related hypertension) of women with GDM compared with women without GDM was not influenced by the GDM diagnostic classification [21].”
A Cluster Randomized Noninferiority Field Trial of Gestational Diabetes Mellitus Screening
Ramezani Tehrani, F., Behboudi-Gandevani, S., Farzadfar, F., Hosseinpanah, F., Hadaegh, F., Khalili, D., Soleymani-Dodaran, M., Valizadeh, M., Abedini, M., Rahmati, M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac181 · Cited by 15
Self-citationTehrani, F. R., Rahmati, M., Farzadfar, F., Abedini, M., Farahmand, M., Hosseinpanah, F., Hadaegh, F., Torkestani, F., Valizadeh, M., Azizi, F., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1039643 · Cited by 19
“5 million non-GDM counterparts, it was reported that applying the IADPSG criteria for GDM diagnosis could significantly increase the prevalence of GDM, while it could not improve the risk of adverse pregnancy outcome compared other criteria (2, 3).”
Self-citationGomes, C. P., Futterman, I. D., Sher, O., Gluck, B., Hillier, T. A., Tehrani, F. R., Chaarani, N., Fisher, N., Berghella, V., & McLaren, R. A. (2024) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2024.101346 · Cited by 17
Review of the Screening Guidelines for Gestational Diabetes Mellitus: How to Choose Wisely
Bakshi, R. K., Kumar, A., Gupta, V., Radhika, A. G., Misra, P., & Bhardwaj, P. (2023) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_298_23 · Cited by 11
Ayele, A. D., Gedefaw, G. A., Alemu, B. K., Wang, Y., & wang, C. C. (2025) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2025-114065 · Cited by 13
Chen, Y., Peng, L. J., He, J., Wu, J., Tian, R., Xu, J., Fan, X., Dai, J., An, R., Song, J., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108201 · Cited by 7
Estimated impact of introduction of new diagnostic criteria for gestational diabetes mellitus
Wit, L. D., Zijlmans, A. B., Rademaker, D., Naaktgeboren, C. A., DeVries, J. H., Franx, A., Painter, R. C., & van Rijn, B. B. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.868 · Cited by 7
Ghasemi, V., Banaei, M., Kiani, Z., Tehrani, F. R., & Naz, M. S. G. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70024 · Cited by 9
Self-citationFirst Trimester Hematological Indices in Gestational Diabetes Mellitus: A Meta-Analysis
Firouzi, F., Tehrani, F. R., Shaharki, H., Mousavi, M., Moradi, N., & Naz, M. S. G. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf043 · Cited by 7
“GDM carries adverse short-term and long-term health outcomes for both mother and her child [5, 10-12].”
Self-citationIdentifying associations between genetic conditions in offspring and pregnancy health complications
Gibson, R. A., Abar, B. M., Elman, L. N., Walsh, K. M., Hurst, J. H., & Cohen, J. L. (2024) · Reproductive Female and Child Health · doi:10.1002/rfc2.80 · Cited by 4
Tehrani, F. R., Sheidaei, A., Rahmati, M., Farzadfar, F., Noroozzadeh, M., Hosseinpanah, F., Abedini, M., Hadaegh, F., Valizadeh, M., Torkestani, F., et al. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003510 · Cited by 4
Self-citationWu, H., Zhang, L., Xie, Z., Cai, H., Zhang, J., & Yu, L. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s500531 · Cited by 7
Zawiejska, A., Bogacz, A., Iciek, R., Lewicka-Rabska, A., Brązert, M., Mikołajczak, P. Ł., & Brązert, J. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01799-3 · Cited by 4
Corrado, F., Benedetto, A. D., Vieste, G. D., Fauci, L. L., Martinelli, C. V., D’Anna, R., & Pintaudi, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133745 · Cited by 3
“However, the diagnostic criteria for GDM are very heterogeneous worldwide [4].”
BackgroundKania, M., Wilk, M., Cyganek, K., & Szopa, M. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01231-2 · Cited by 2
“The authors concluded that this data should inform health-care-providers in the choice of the most cost-effective approach for GDM screening [20].”
Shi, Y., & Meng, X. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3084522 · Cited by 1
RetractedSpecial Issue: “Clinical Diagnosis and Management of Pregnancy Complications”
Gabbay‐Benziv, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195644 · Cited by 2
Brunton, N. M., Friesen, K. J., Yamamoto, J. M., Prior, H. J., & McGavock, J. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.11.005 · Cited by 1
Dur, R., Baş, A., & Dur, G. (2026) · Biological Trace Element Research · doi:10.1007/s12011-026-05033-5
AI-Powered Framework for Identifying Maternal Diagnostic Biomarkers of Gestational Diabetes Mellitus
Kiruthika, V., Madhumitha, R., Karishma, K., Deepika, V., & Krishnan, D. (2026) · Communications in computer and information science · doi:10.1007/978-3-032-16830-6_9
Yu, R., Liu, X., & Zhang, S. (2026) · BMC Medical Genomics · doi:10.1186/s12920-026-02401-x
“…diabetes mellitus (GDM) is a metabolic disorder of pregnancy driven by an imbalance between the degree of insulin resistance and the β-cell secretory capacity, cul-minating in pathological hyperglycemia, and poses a significant health concern for pregnant women, affecting 4%-12% of pregnancies [2].”
Fallah, M., Mousavi, M., Tabashiri, A., Firouzi, F., Azizi, F., Tehrani, F. R., & Behboudi‐Gandevani, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1918348
Self-citationShaken in Utero: Earthquakes and Unpredictable Stress
Seema, M., Afoakwah, C., & Byrnes, J. (2026) · Springer eBooks · doi:10.1007/978-981-92-3745-6_5
Liu, Q., Mayer, D. F. R., Harding, J. E., Gamble, G. D., Dawes, L. K., Crowther, C. A., & Lin, L. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag448
Metadata
- Authors
- Ramezani Tehrani, F., Naz, M. S. G., Yarandi, R. B., & Behboudi-Gandevani, S.
- Affiliations
- Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran
- Research Institute for Endocrine Sciences (IR)
- Faculty of Nursing and Health Sciences, Nord University, 8049 Bodø, Norway
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-02-09
- Volume
- 10
- Issue
- 4
- Pages
- 666
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7916110
- OpenAlex
- W3126866213
- Cited by
- 34
- References
- 83
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 3
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Funders
- National Institutes for Medical Research Development (NIMAD) (972438)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- gestational diabetes mellitus, diagnostic criteria, adverse maternal outcomes, IADPSG criteria, primary cesarean section, labor induction, maternal hemorrhage, pregnancy-related hypertension, universal screening, diagnostic thresholds, GDM prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.